Lv4
510 积分 2024-09-03 加入
Diagnostic Utility of a 90-Gene Expression Assay (Canhelp-Origin) for Patients with Metastatic Cancer with an Unclear or Unknown Diagnosis
3天前
已完结
Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial
3天前
已完结
PT1.07.03 Adjuvant Osimertinib in IB-IIIB NSCLC with Uncommon EGFR Mutations (Admin): Mutation Profile and ctDNA Dynamics
7天前
已关闭
病原体宏基因组高通量测序产品技术审评重点关注点探讨
24天前
已完结
Galleri cancer test: NHS trial of controversial early detection tool fails to meet main aim, results confirm
1个月前
已关闭
Potential of Minimal Residual Disease in Guiding Adjuvant Therapy Decisions in Non–Small Cell Lung Cancer
1个月前
已完结
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer
1个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC
3个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
3个月前
已完结
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
4个月前
已完结
Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702
4个月前
已采纳
Comparison of hyaluronic acid, hypochlorous acid, and flurbiprofen on postoperative morbidity in palatal donor area: a randomized controlled clinical trial
1年前
已采纳
皖公网安备34019202002308
